New Key Statistics Module, Z-Score and F-Score
OTCPK:SBHMY Key Ratios
Market Cap $ M | 7,282.16 |
Enterprise Value $ M | 8,081.92 |
P/E(ttm) | 27.82 |
PE Ratio without NRI | 28.46 |
Forward PE Ratio | 16.74 |
Price/Book | 1.91 |
Price/Sales | 2.27 |
Price/Free Cash Flow | 12.33 |
Price/Owner Earnings | 41.11 |
Payout Ratio % | 0.39 |
Revenue (TTM) $ M | 3,856.00 |
EPS (TTM) $ | 0.34 |
Beneish M-Score | -2.73 |
10-y EBITDA Growth Rate % | 14.50 |
5-y EBITDA Growth Rate % | -6.80 |
y-y EBITDA Growth Rate % | 24.10 |
EV-to-EBIT | 9.26 |
EV-to-EBITDA | 9.26 |
PEG | -- |
Shares Outstanding M | 910.27 |
Net Margin (%) | 14.68 |
Operating Margin % | 21.70 |
Pre-tax Margin (%) | 21.47 |
Quick Ratio | 1.07 |
Current Ratio | 1.15 |
ROA % (ttm) | 6.22 |
ROE % (ttm) | 13.07 |
ROIC % (ttm) | 9.71 |
Dividend Yield % | 2.56 |
Altman Z-Score | 2.71 |
SBHMY Number of Guru Trades
SBHMY Volume of Guru Trades
Gurus Latest Trades with OTCPK:SBHMY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SBHMY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sino Biopharmaceutical Ltd Insider Transactions
No Available Data
News about OTCPK:SBHMY
Total 0- 1